Stress management intervention for stress maladjustment in inflammatory bowel disease patients

Stress management intervention for stress maladjustment in inflammatory bowel disease patients - Stress management intervention in inflammatory bowel disease patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035588

Enrollment

Registered

2019-01-18

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease

Interventions

Mindfulness, a type of stress management, is conducted for 2 hours once a week (six times in total).

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inflammatory bowel disease patients aged >=18 years in remission phase (CRP<2, 0<=IOIBD<2).

Exclusion criteria

Exclusion criteria: Inflammatory bowel disease patients being treated with prednisolone. Inflammatory bowel disease patients with CRP>=2 and IOIBD>=2.

Design outcomes

Primary

Measure	Time frame
Before and after stress management intervention (6 weeks), the following data are analyzed and evaluated: beta-endorphin, adrenaline, noradrenaline, CRH, ACTH, cortisol, IL-6, TNFalpha, Japanese version of the General Self-Efficacy Scale, sense of coherence, Japanese Perceived Stress Scale, Tokyo University Egogram New Vern2.	—

Countries

Japan

Contacts

Public ContactTsukasa Kuroki

Fukuoka International University of Health and Welfare Department of nursing

tkuroki@takagigakuen.ac.jp0924070805

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026